Related Experiment Videos
Thoracoscopy and talc poudrage for pneumothoraces and effusions
T M Daniel1, C G Tribble, B M Rodgers
1Department of Surgery, University of Virginia Health Sciences Center, Charlottesville 22908.
The Annals of Thoracic Surgery
|August 1, 1990
Summary
Thoracoscopic talc poudrage effectively treats pneumothorax and recurrent pleural effusions in chronically ill patients. This minimally invasive procedure demonstrates high success rates with low morbidity and mortality when patients are carefully selected.
Area of Science:
- Thoracic Surgery
- Pulmonology
- Minimally Invasive Procedures
Background:
- Recurrent pleural effusions and pneumothorax pose significant challenges in chronically ill patients.
- Existing treatments may have limitations in efficacy or invasiveness.
Purpose of the Study:
- To report the indications, technique, and outcomes of thoracoscopic talc poudrage.
- To evaluate the efficacy and safety of this procedure in managing pneumothorax and recurrent pleural effusions.
Main Methods:
- Retrospective analysis of 40 patients undergoing thoracoscopic talc poudrage between 1982 and 1989.
- Patients included those with pneumothorax (e.g., cystic fibrosis, COPD) and chronic effusions (e.g., malignant, chylothorax).
Main Results:
- Successful treatment achieved in 95% of pneumothorax patients (19/20) and 90% of effusion patients (18/20).
- Two hospital deaths occurred, unrelated to the talc poudrage procedure itself.
- Low morbidity and mortality observed with appropriate patient selection.
Conclusions:
- Thoracoscopic talc poudrage is an effective treatment for selected patients with pneumothorax and recurrent pleural effusions.
- The procedure offers a low morbidity and mortality profile.
- Optimizing patient selection and procedural technique enhances treatment outcomes.